2594 Safety and efficacy of Temsirolimus (Torisel®) as second line treatment for patients with recurrent bladder cancer. (September 2015) - Houede, N.; Roubaud, G.; Mahammedi, H.; Vedrine, L.; Joly, F.; Mourey, L.; Pfister, C.; Culine, S.; Goberna, A.; Lortal, B.; Pulido, M.; Pourquier, P.; et al.